Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : email@example.com
|Molecular Profile||Indication/Tumor Type||Response Type||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|Unknown unknown||acute myeloid leukemia||not applicable||Liposomal Annamycin||Phase Ib/II||Actionable||In a Phase I/II trial, Liposomal annamycin demonstrated safety and preliminary efficacy, resulted in complete clearing of circulating peripheral blasts in 62% (5/8) of patients with relapsed or refractory acute lymphoblastic leukemia (PMID: 23763920).||23763920|